Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
PDS01ADC
Docetaxel
+3 more
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
February 23, 2021
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
April 8, 2026
NCT07164443
NCT07072728
NCT03354416
NCT04887935
NCT05600400
NCT05653063
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions